Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
SUPPLEMENTARY DATA Exenatide: The Investigator’s brochure from Eli Lilly and Company (http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf) indicates that the ‘mean apparent clearance
Add to Reading List
Document Date: 2014-06-20 11:12:30
Open Document
File Size: 649,96 KB
Share Result on Facebook
Company
Merck /
Eli Lilly and Company /
/
MedicalCondition
diabetes /
/
Organization
American Diabetes Association /
/
Person
Glimepiride /
Exenatide /
Sitagliptin /
/
Position
Investigator /
/
Product
glucagon /
Glimepiride /
/
Technology
pharmacokinetics /
/
URL
http /
SocialTag
Gastroenterology
Exenatide
Sitagliptin
Glucagon-like peptide-1
Glimepiride
Dipeptidyl peptidase-4 inhibitor
Glucose tolerance test
Anti-diabetic drugs
Endocrine system
Chemistry